Back to feed
H.R. 124
In Committee
2%pass
Byron Nash Renal Medullary Carcinoma Awareness Act of 2023
Sponsor: Rep. Green, Al [D-TX-9] (D)
Healthcare
1Passage Analysis
stale
0.5
status base
0.05
minority sponsor
0.7
~7% of bills become law. Low passage odds are normal and expected. Model based on structural factors only; does not use trading data.
2Who is Positioned
No detected financial positioning for this bill.
Recent Trades in Affected Tickers
No recent trades in affected tickers.